Drug Designing: Open Access
Open Access

New emerging treatment strategies for multiple sclerosis

International Conference and Exhibition on Computer Aided Drug Design & QSAR

October 29-31, 2012 DoubleTree by Hilton Chicago-North Shore, USA

Mike Namaka

Accepted Abstracts: Drug Design

Abstract :

Multiple Sclerosis: Section 1: Objectives: At the end of this section, you will be able to: ? Understand what constitutes the diagnosis of multiple sclerosis (MS). ? Identify the classification of the various types of MS. ? Describe the pathophysiology involved in MS. ? Describe the diagnostic tests used to diagnose and treat MS. ? Describe the clinical presentations of MS. ? Understand the current treatment strategies for MS. Define terms: ? Multiple Sclerosis (MS) ? Relapse ? Relapsing Remitting MS ? Secondary Progressive MS ? Primary Progressive MS ? Progressive Relapsing MS ? Clinically Isolated Syndrome ? Optic Neuritis ? Autoimmune disease ? Inflammatory Cytokines ? Th 1 & Th 2 cells ? Antigen presenting cells (macrophages, monocytes and dendritic cells) ? Antigen ? Adhesion Molecules (ICAM-1; VCAM-1) ? Oligodendrocytes ? Myelin ? Lesions ? Blood brain barrier ? Central nervous system myelin proteins (MBP, PLP,MAG, MOG)